Lanean...
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy
Almost 100 mutations in the human transthyretin (TTR) gene cause the autosomal dominant disorders of familial amyloidotic polyneuropathy (FAP) and familial amyloidotic cardiomyopathy. While these have been clinically classified as separate disorders, the peripheral and autonomic nervous systems and...
Gorde:
| Argitaratua izan da: | Degener Neurol Neuromuscul Dis |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dove Medical Press
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065585/ https://ncbi.nlm.nih.gov/pubmed/30890886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S24624 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|